Remimazolam for Cataract Surgery

Recruiting now · Phase 4

Conditions studied: Cataract Surgery, Cognitive Impairment

In brief

The goal of this study is to assess any post operative cognitive changes following benzodiazepine administration during cataract surgery. The investigators will compare effects of Midazolam vs. Remimazolam on cognition at the time of discharge from the post operative care unit and the next day following surgery. Cognitive changes will be assessed by administration of Montreal Cognitive Assessment (MoCA). Participants will: 1. Complete MoCA testing prior to surgery 2. Randomize in either Midazolam or study drug Remimazolam 3. Complete MoCA testing after surgery at the time of discharge in the post anesthesia care unit and the next day of surgery at the time of post operative surgical visit. 4. Complete Patient Satisfaction Survey at the time of discharge from the Post Anesthesia Care Unit (PACU)

Key facts

Study ID

NCT05980117

Run by

University of California, Los Angeles

People needed

120

Starts

2025-03-10

Expected to finish

2026-01-01

Last updated by the study team

2025-03-19

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients age > 65 years undergoing first eye cataract surgery under local topical anesthesia at the University of California, Los Angeles (UCLA).
• Both male and female patients
• American Society of Anesthesiologists Class 2, 3, and 4.

You may not qualify if…

• Patients who are unable to consent for the study
• Patients who are unable to cooperate with the cognitive assessment such as patients with significant visual, auditory, language or other impairment.
• Patients who are unable to understand simple English commands.
• Patients who do not wish to have benzodiazepine medication during surgery
• Patients with a history of severe hypersensitivity reaction to dextran 40 or products containing dextran 40.
• Patients with chronic pain on opiates.
• Patients with a history of drug, alcohol abuse/dependence.
• Patients with BMI > 40.
• Patients with obstructive sleep apnea (moderate to severe).

Where it is running

• Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.